UROPLASTY INC-NEW
UPI
UPI was delisted on the 31st of March, 2015.
32 hedge funds and large institutions have $32.3M invested in UROPLASTY INC-NEW in 2013 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 10 increasing their positions, 7 reducing their positions, and 5 closing their positions.
43% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 7
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
6% less funds holding
Funds holding: 34 → 32 (-2)
18% less capital invested
Capital invested by funds: $39.3M → $32.3M (-$7M)
40% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCP
Rothschild Capital Partners
New York
|
+$750K |
| 2 |
CAM
Cortina Asset Management
Milwaukee,
Wisconsin
|
+$201K |
| 3 |
N
Natixis
Paris,
France
|
+$48.2K |
| 4 |
PA
Perceptive Advisors
New York
|
+$30.5K |
| 5 |
WPC
White Pine Capital
Bloomington,
Minnesota
|
+$20.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TAM
THB Asset Management
Norwalk,
Connecticut
|
-$572K |
| 2 |
CCA
Catalyst Capital Advisors
Huntington,
New York
|
-$251K |
| 3 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
-$169K |
| 4 |
SC
Sophrosyne Capital
New York
|
-$137K |
| 5 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$58.4K |
UPI Hedge Fund Activity: Q4 2013 in Review
32 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in UROPLASTY INC-NEW (UPI) for Q4 2013, worth a combined $32.3M — down 18% from $39.3M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of UPI and 3 opened new positions — a net loss of 2 holders — while 7 trimmed existing stakes and 10 added.
The largest buyer was Rothschild Capital Partners, adding an estimated $750K. The largest seller was THB Asset Management, cutting an estimated $572K.
- 32 institutional investors held UROPLASTY INC-NEW (UPI) as of Q4 2013, down from 34 in Q3 2013.
- Funds reported $32.3M of UROPLASTY INC-NEW stock for Q4 2013, down 18% quarter-over-quarter.
- 3 funds opened new UROPLASTY INC-NEW positions in Q4 2013 and 5 closed out, a net change of -2 holders.
- The largest UROPLASTY INC-NEW buyer in Q4 2013 was Rothschild Capital Partners, an estimated $750K added.
- The largest UROPLASTY INC-NEW seller in Q4 2013 was THB Asset Management, an estimated $572K sold.
Based on aggregated 13F filings for Q4 2013.